<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01482416</url>
  </required_header>
  <id_info>
    <org_study_id>E.FR - 245365</org_study_id>
    <nct_id>NCT01482416</nct_id>
  </id_info>
  <brief_title>Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery</brief_title>
  <acronym>EDILA</acronym>
  <official_title>Flow-mediated Evaluation of the Brachial Artery of Climacteric Women Using Estradiol and Placebo. Randomized, Double Blinded, Placebo Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the vascular effects of estrogens on climacteric women
      measured by flow-mediated evaluation of the brachial artery using high resolution ultrasound
      and compare to placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The interruption of the secretion of sex steroids that occurs after menopause, determines a
      change in vascular pattern at various levels. As a result, several side effects might appear
      and interfere with women's quality of life and health. The use of hormone replacement therapy
      has contributed to the improvement in these effects. It has been observed vascular beneficial
      effects of sex steroids in premenopausal women, and of hormone replacement therapy (HRT) in
      climacteric women, on the central retinal arteries. The objective of this study is to
      evaluate the effects of conjugated equine estrogen on flow-mediated dilation of the brachial
      artery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flow-mediated dilation of the brachial artery</measure>
    <time_frame>one month after treatment started</time_frame>
    <description>Flow-mediated dilation will be measured by high resolution ultrasound</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Unspecified Injury of Brachial Artery, Left Side, Initial Encounter</condition>
  <arm_group>
    <arm_group_label>Estrogen use</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>climacteric women will use conjugated equine estrogens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>use of Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>climacteric women will use placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Estrogens, Conjugated (USP)</intervention_name>
    <description>Experimental group will use 0.625mg/day during 30 days</description>
    <arm_group_label>Estrogen use</arm_group_label>
    <other_name>Premarin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo group will use placebo once/day during 30 days</description>
    <arm_group_label>use of Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women without menstrual cycles within the last 12 months and FSH &gt; 30IU/L

          -  Healthy women

          -  Women that were not using drugs with potential vascular effect within the last 1 year

          -  Women that never used hormone replacement therapy

        Exclusion Criteria:

          -  Smoking

          -  Blood Pressure &gt; 160/90 mm Hg.

          -  Breast and or endometrial cancer

          -  History of acute myocardial infarction

          -  Diabetes

          -  Vaginal bleeding of any origin

          -  Hepatic disease

          -  Thrombophlebitis or thromboembolic disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Selmo Geber, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical School of Universidade Federal de Minas Gerais</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital das Clinicas - Universidade Federal de Minas Gerais</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30130100</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Faria AF, de Souza MA, Geber S. Vascular resistance of central retinal artery is reduced in postmenopausal women after use of estrogen. Menopause. 2011 Aug;18(8):869-72. doi: 10.1097/gme.0b013e31820cc60c.</citation>
    <PMID>21471823</PMID>
  </reference>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2011</study_first_submitted>
  <study_first_submitted_qc>November 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2011</study_first_posted>
  <last_update_submitted>August 13, 2014</last_update_submitted>
  <last_update_submitted_qc>August 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Minas Gerais</investigator_affiliation>
    <investigator_full_name>Selmo Geber</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>hormone replacement therapy</keyword>
  <keyword>Doppler velocimetry</keyword>
  <keyword>Flow-mediated dilation</keyword>
  <keyword>menopause</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Estrogens</mesh_term>
    <mesh_term>Estrogens, Conjugated (USP)</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

